达嘉维康:预计2025年度净利润亏损2.5亿元~3亿元

Group 1 - The company, Dajia Weikang, expects a net profit loss of 250 million to 300 million yuan for the year 2025, marking a shift from profit to loss year-on-year [1] - The primary reasons for the performance change include increased competition, macroeconomic environment changes, industry policy adjustments, and shifts in consumer habits, leading to a temporary decline in the company's chain pharmacy segment [1] - The underperformance of a recently acquired subsidiary, influenced by the aforementioned industry conditions and operational challenges, resulted in significant asset impairment losses due to goodwill impairment testing, which adversely affected the current profit [1]

Hunan Dajiaweikang Pharmaceutical Industry -达嘉维康:预计2025年度净利润亏损2.5亿元~3亿元 - Reportify